Patients who research medical information online are likely to be more concerned about switching from originator products to biosimilars, according to the study.
A New Zealand study of patients with rheumatic conditions suggests that providers need to be mindful of patient attitudes toward biosimilars to prevent biased therapy choices and poor outcomes.
Patients who do online searching for medical information about biosimilars are liable to have exacerbated concerns about switching to biosimilars, according to the study, which examined patient attitudes toward these agents. The findings also indicated that women are more likely to have concerns about switching from originator drugs to biosimilars.
Among the findings:
To read more about the findings, visit The Center for Biosimilars.